Literature DB >> 21911388

Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation.

Carmen Chak-Lui Wong1, Daniele M Gilkes, Huafeng Zhang, Jasper Chen, Hong Wei, Pallavi Chaturvedi, Stephanie I Fraley, Chun-Ming Wong, Ui-Soon Khoo, Irene Oi-Lin Ng, Denis Wirtz, Gregg L Semenza.   

Abstract

Primary tumors facilitate metastasis by directing bone marrow-derived cells (BMDCs) to colonize the lungs before the arrival of cancer cells. Here, we demonstrate that hypoxia-inducible factor 1 (HIF-1) is a critical regulator of breast cancer metastatic niche formation through induction of multiple members of the lysyl oxidase (LOX) family, including LOX, LOX-like 2, and LOX-like 4, which catalyze collagen cross-linking in the lungs before BMDC recruitment. Only a subset of LOX family members was expressed in any individual breast cancer, but HIF-1 was required for expression in each case. Knockdown of HIF-1 or hypoxia-induced LOX family members reduced collagen cross-linking, CD11b(+) BMDC recruitment, and metastasis formation in the lungs of mice after orthotopic transplantation of human breast cancer cells. Metastatic niche formation is an HIF-1-dependent event during breast cancer progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21911388      PMCID: PMC3182724          DOI: 10.1073/pnas.1113483108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

Review 1.  Lysyl oxidases: a novel multifunctional amine oxidase family.

Authors:  K Csiszar
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2001

2.  Lysyl oxidase is essential for hypoxia-induced metastasis.

Authors:  Janine T Erler; Kevin L Bennewith; Monica Nicolau; Nadja Dornhöfer; Christina Kong; Quynh-Thu Le; Jen-Tsan Ashley Chi; Stefanie S Jeffrey; Amato J Giaccia
Journal:  Nature       Date:  2006-04-27       Impact factor: 49.962

3.  Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.

Authors:  Reinhard Bos; Petra van der Groep; Astrid E Greijer; Avi Shvarts; Sybren Meijer; Herbert M Pinedo; Gregg L Semenza; Paul J van Diest; Elsken van der Wall
Journal:  Cancer       Date:  2003-03-15       Impact factor: 6.860

4.  Selective upregulation and amplification of the lysyl oxidase like-4 (LOXL4) gene in head and neck squamous cell carcinoma.

Authors:  T Görögh; J B Weise; C Holtmeier; P Rudolph; J Hedderich; S Gottschlich; M Hoffmann; P Ambrosch; K Csiszar
Journal:  J Pathol       Date:  2007-05       Impact factor: 7.996

Review 5.  Paradoxical roles for lysyl oxidases in cancer--a prospect.

Authors:  Stacey L Payne; Mary J C Hendrix; Dawn A Kirschmann
Journal:  J Cell Biochem       Date:  2007-08-15       Impact factor: 4.429

6.  Matrix crosslinking forces tumor progression by enhancing integrin signaling.

Authors:  Kandice R Levental; Hongmei Yu; Laura Kass; Johnathon N Lakins; Mikala Egeblad; Janine T Erler; Sheri F T Fong; Katalin Csiszar; Amato Giaccia; Wolfgang Weninger; Mitsuo Yamauchi; David L Gasser; Valerie M Weaver
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

7.  Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha.

Authors:  Sreenivasulu Chintala; Károly Tóth; Shousong Cao; Farukh A Durrani; Mary M Vaughan; Randy L Jensen; Youcef M Rustum
Journal:  Cancer Chemother Pharmacol       Date:  2010-01-12       Impact factor: 3.333

8.  Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche.

Authors:  Janine T Erler; Kevin L Bennewith; Thomas R Cox; Georgina Lang; Demelza Bird; Albert Koong; Quynh-Thu Le; Amato J Giaccia
Journal:  Cancer Cell       Date:  2009-01-06       Impact factor: 31.743

9.  Differential expression of the LOX family genes in human colorectal adenocarcinomas.

Authors:  Youngho Kim; Seonae Roh; Jung-Young Park; Yangsik Kim; Dong Hyung Cho; Jin Cheon Kim
Journal:  Oncol Rep       Date:  2009-10       Impact factor: 3.906

10.  Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1.

Authors:  G L Semenza; B H Jiang; S W Leung; R Passantino; J P Concordet; P Maire; A Giallongo
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

View more
  182 in total

Review 1.  HIF transcription factors, inflammation, and immunity.

Authors:  Asis Palazon; Ananda W Goldrath; Victor Nizet; Randall S Johnson
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

Review 2.  Action and reaction: the biological response to siRNA and its delivery vehicles.

Authors:  Rosemary L Kanasty; Kathryn A Whitehead; Arturo J Vegas; Daniel G Anderson
Journal:  Mol Ther       Date:  2012-01-17       Impact factor: 11.454

Review 3.  Hypoxia-inducible factors in physiology and medicine.

Authors:  Gregg L Semenza
Journal:  Cell       Date:  2012-02-03       Impact factor: 41.582

4.  Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules.

Authors:  Anand Ramteke; Harold Ting; Chapla Agarwal; Samiha Mateen; Ranganathan Somasagara; Anowar Hussain; Michael Graner; Barbara Frederick; Rajesh Agarwal; Gagan Deep
Journal:  Mol Carcinog       Date:  2013-12-17       Impact factor: 4.784

5.  ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis.

Authors:  Yan Chen; Bo Zhang; Lei Bao; Lai Jin; Mingming Yang; Yan Peng; Ashwani Kumar; Jennifer E Wang; Chenliang Wang; Xuan Zou; Chao Xing; Yingfei Wang; Weibo Luo
Journal:  J Clin Invest       Date:  2018-04-09       Impact factor: 14.808

6.  Lysyl Oxidase-like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer.

Authors:  Fernando Salvador; Alberto Martin; Celia López-Menéndez; Gema Moreno-Bueno; Vanesa Santos; Alberto Vázquez-Naharro; Patricia G Santamaria; Saleta Morales; Pierre R Dubus; Laura Muinelo-Romay; Rafael López-López; Jason C Tung; Valerie M Weaver; Francisco Portillo; Amparo Cano
Journal:  Cancer Res       Date:  2017-07-18       Impact factor: 12.701

7.  Anthracycline inhibits recruitment of hypoxia-inducible transcription factors and suppresses tumor cell migration and cardiac angiogenic response in the host.

Authors:  Tetsuhiro Tanaka; Junna Yamaguchi; Kumi Shoji; Masaomi Nangaku
Journal:  J Biol Chem       Date:  2012-08-20       Impact factor: 5.157

Review 8.  Cancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis.

Authors:  G L Semenza
Journal:  Oncogene       Date:  2012-12-10       Impact factor: 9.867

9.  Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis.

Authors:  Ting Wang; Daniele M Gilkes; Naoharu Takano; Lisha Xiang; Weibo Luo; Corey J Bishop; Pallavi Chaturvedi; Jordan J Green; Gregg L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-17       Impact factor: 11.205

10.  Hypoxia-inducible factor 1 (HIF-1) promotes extracellular matrix remodeling under hypoxic conditions by inducing P4HA1, P4HA2, and PLOD2 expression in fibroblasts.

Authors:  Daniele M Gilkes; Saumendra Bajpai; Pallavi Chaturvedi; Denis Wirtz; Gregg L Semenza
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.